More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$4.73B
EPS
-0.52
P/E ratio
--
Price to sales
0.79
Dividend yield
--
Beta
1.84838
Previous close
$28.35
Today's open
$28.19
Day's range
$28.19 - $28.74
52 week range
$10.43 - $29.90
show more
CEO
Drew Wilkerson
Employees
6906
Headquarters
Charlotte, NC
Exchange
New York Stock Exchange
Shares outstanding
164951056
Issue type
Common Stock
Industrials
Transportation
RXO Q3 Earnings & Revenues Beat Estimates on Brokerage Strength
RXO's Q3 2026 earnings surge 800% as revenues rise 31.7%, driven by brokerage strength and higher freight rates, despite margin pressure and rising costs.
Zacks Investment Research • 2 hours ago

RXO's Latest Curve Freight Market Forecast Marks the Tenth Consecutive Quarter of Spot Rate Inflation
CHARLOTTE, N.C.--(BUSINESS WIRE)---- $RXO #nyse--RXO (NYSE: RXO), a leading provider of asset-light transportation solutions, today released the latest update to its proprietary Curve truckload market forecast, which shows strong year-over-year spot rate growth, excluding the impacts of fuel. In the third quarter, spot rates, as measured by the Curve, started off strong in July. Though rates moderated in August and September, the index still finished the quarter at 37.9%, its highest level since 2021 and an i.
Business Wire • Nov 17, 2026

C.H. Robinson Worldwide Targets $300 Million in RXO Savings as Freight Costs Rise
C.H. Robinson Worldwide NASDAQ: CHRW executives said the freight broker plans to continue investing in organic growth while pursuing its RXO acquisition, with Chief Financial Officer Damon Lee pointing to anticipated cost savings and reduced debt as key benefits of the deal.
MarketBeat • Nov 14, 2026

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: ADT Inc. (NYSE – ADT), RXO Inc. (NYSE – RXO), PTC Inc. (Nasdaq – PTC), Lifecore Biomedical, Inc. (Nasdaq – LFCR)
BALA CYNWYD, Pa., Nov. 11, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.
GlobeNewsWire • Nov 11, 2026

INVESTIGATION ALERT - The M&A Class Action Firm Is Investigating the Merger – OPCH, PTC, RXO and SYNA - IS IT A FAIR DEAL FOR YOU?
NEW YORK, Nov. 04, 2026 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2025 ISS Securities Class Action Services Report. We are headquartered on the 47th floor in the Empire State Building in New York City and are investigating if below deal is fair:
GlobeNewsWire • Nov 4, 2026

RXO Delivers Strong Third-Quarter Results with Profitable Growth and Continued Market Share Gains
CHARLOTTE, N.C.--(BUSINESS WIRE)---- $RXO #nyse--RXO (NYSE: RXO) today reported strong third-quarter financial results. RXO Chairman and CEO Drew Wilkerson said, “We exceeded the high end of our third-quarter profit outlook, demonstrating the momentum we're building across RXO. We continued to take market share in Brokerage, and achieved a 3 percent increase in truckload volume, outperforming the market. We achieved a 900 basis-point sequential increase in truckload spot mix, which helped drive the best seque.
Business Wire • Oct 29, 2026

RXO (RXO) Q3 Earnings and Revenues Top Estimates
RXO (RXO) came out with quarterly earnings of $0.09 per share, beating the Zacks Consensus Estimate of $0.08 per share. This compares to earnings of $0.01 per share a year ago.
Zacks Investment Research • Oct 29, 2026

RXO (RXO) Reports Q3 Earnings: What Key Metrics Have to Say
The headline numbers for RXO (RXO) give insight into how the company performed in the quarter ended September 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Zacks Investment Research • Oct 29, 2026

Despite Fast-paced Momentum, RXO (RXO) Is Still a Bargain Stock
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, RXO (RXO) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
Zacks Investment Research • Oct 22, 2026

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Silence Therapeutics plc (Nasdaq – SLN), Option Care Health, Inc. (Nasdaq – OPCH), RXO Inc. (NYSE – RXO), Sangoma Technologies Corporation (Nasdaq – SANG)
BALA CYNWYD, Pa., Oct. 20, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.
GlobeNewsWire • Oct 20, 2026

¹ Disclosures

Open an M1 investment account to buy and sell RXO Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.